--- title: Analytics and reporting | Nextvisit description: Cohort outcomes, practice performance, study-grade reports, and AriaMD-scheduled delivery. Provider+; some study and export modes are enterprise. url: "http://localhost:3000/analytics" type: static generatedAt: "2026-09-04T06:57:01.098Z" --- Analytics and reporting # The panel as a single rollup, plus reports AriaMD writes for you. Available on Provider+. Clinical-study and custom-export modes are enterprise. nextvisit.app/analytics/outcomesPHQ-9 6.2at week 16, mean66% lowervs baselineDepressioncohort selected Response and remission bands use standard cutoffs. Click a cohort pill to swap the scale. Any aggregate drills to the patients underneath. nextvisit.app/analytics/practice0Active panelacross all providers0.0%No-show ratelast 30 days0Net promoterclinician NPS0Days in ARmean across payersTop medications - Sertraline312 - Bupropion254 - Lamotrigine198 - Vyvanse174 - Lithium142 - Buspirone121 Top diagnoses - Depression38% - Anxiety27% - ADHD14% - Bipolar11% - Other10% nextvisit.app/analytics/reports/mat-weekly #### Abstract Across 312 buprenorphine inductions over 8 quarters, retention at 90 days was 78%, with COWS reduction of 9.4 (95% CI 8.7 to 10.1) from baseline. Concurrent counseling participation averaged 71% (n=222 of 312). 14 inductions were terminated for diversion concerns; 7 of 14 transitioned to a higher level of care. #### Methods Retrospective analysis of all signed encounters tagged MAT in the workspace. COWS scores, UDS results, and counseling attendance pulled from the structured fields on each visit note. No free-text mining; results derive from the same fields the chart uses. #### Results - **Retention 90 days:** 78% (243 of 312) - **COWS reduction baseline to wk 12:** 9.4 (CI 8.7 to 10.1) - **UDS positive for prescribed buprenorphine at wk 12:** 92% - **Counseling adherence:** 71% mean across cohort - **Adverse events:** 4 documented, 0 serious Every claim links to the source encounters. Counts come from structured fields on signed notes. Enterprise adds longer cohort windows, multi-workspace pooling, and custom CI methods. nextvisit.app/automations/scheduled-reportAriaMD promptRecurring · Mon 09:00 PatientsEncountersDocumentsWeb searchDeliveryPDF · branded ``` patient_id,name,dose_mg,cows,counseling p-2841,J. R.,16,3,wk p-3019,M. A.,12,5,bi-wk p-4422,T. S.,24,2,wk p-4815,A. L.,8,7,wk p-5006,R. K.,16,4,bi-wk ``` ``` { "report": "mat_weekly", "n": 312, "metrics": { "retention_90d": 0.78, "cows_delta": -9.4, "counseling_pct": 0.71 } } ``` **# MAT outcomes, week 04-19** **n=312** active inductions, 78% 90-day retention. - COWS reduction: 9.4 (CI 8.7 to 10.1) - Counseling: 71% - Adverse events: 4 (0 serious) From AriaMD Subj MAT weekly · 04-19-2026 312 inductions this week. 78% 90-day retention, COWS down 9.4 from baseline. Full PDF and panel CSV attached. - Daily, weekday, weekly, monthly, or event-triggered cadence - PDF, CSV, JSON, Markdown, plain email, or a layout you describe in the prompt - Email to a clinician or list, automation event, or webhook - Patients and Encounters on by default; Documents and web search opt in - 10,000 prompt characters, four intelligence levels, scoped tools per task What you need to run it ### Provider+ for the dashboards and scheduled reports. Outcomes, practice performance, and AriaMD-authored reports ship on Provider+. Enterprise adds clinical-study mode, multi-workspace pooling, custom export formats, brand templates, and longer cohort windows. [See pricing](/pricing) [Talk to sales for enterprise](/contact) See your panel as a single rollup ## Twenty minutes. We open one of your real workspaces (or a sample) and walk the analytics view. Cohort outcomes, practice KPIs, a study-grade rollup, and one scheduled report to your inbox. [Book a demo](https://nextvisit.cal.com/ryan/demo) [Talk to sales](mailto:hello@nextvisit.ai) Live in 2 weeks or less BAA signed by default